Bloomage BioTechnology

About:

Bloomage BioTechnology is a injectable hyaluronan soft tisse filling gel

Website: http://www.bloomagebio-tech.com/e/index.php

Twitter/X: bloomagebiotech

Top Investors: GIC, Larry Zhao

Description:

Bloomage BioTechnology (the “Company”, collectively referred to as the “Group” together with its subsidiaries), founded on 3rd April, 2006 in the Cayman Islands, is an International Group dedicated to develop in the field of biomedicine. Its core subsidiary is a manufacturer and distributor of sodium hyaluronic acid (referred to as “HA”) and focuses mainly on the development, manufacture and sale of various HA raw materials and end products. The Group has been listed on the Main Board of the Stock Exchange of Hong Kong with the stock code 00963.

Total Funding Amount:

$95.3M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Beijing, Beijing, China

Founded Date:

1998-01-01

Contact Email:

info(AT)biobloomage.com

Founders:

Number of Employees:

501-1000

Last Funding Date:

2023-09-29

IPO Status:

Public

Industries:

© 2025 bioDAO.ai